News Details

(As on May 29, 2025, 15:56)

Back

AstraZeneca receives CDSCO a pproval for Lung Cancer Drug

AstraZeneca Pharma India announced on Thursday that it has received regulatory approval for the import, sale, and distribution of its lung cancer treatment drug.

The Central Drugs Standard Control Organisation (CDSCO) has approved Osimertinib tablets in 40mg and 80mg strengths, the company said in a statement.

This approval is a significant milestone, enabling the use of Osimertinib as a monotherapy for patients with locally advanced, unresectable (Stage III) non-small cell lung cancer (NSCLC), the statement added.

ATTENTION INVESTORS

"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.......... Issued in the interest of investors". "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with us. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day.......... Issued in the interest of investors". "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary".

(Note : Best viewed in 1024 X 768 and above resolution also in IE 9 and above all higher versions.)

Designed, developed and content provided by

News

News Details

SMS Registration

Mobile Trading

Investors Grievances

Invest By QFI

CLIENT LOGIN

FRANCHISEE LOGIN

INTERNET TRADING